The anti-allergic drug, N-(3',4'-dimethoxycinnamonyl) anthranilic acid, exhibits potent anti-inflammatory and analgesic properties in arthritis
about
Human genetics in rheumatoid arthritis guides a high-throughput drug screen of the CD40 signaling pathwayIndoleamine 2,3-dioxygenase-1 is protective in atherosclerosis and its metabolites provide new opportunities for drug developmentProduction of hydroxycinnamoyl anthranilates from glucose in Escherichia coliKynurenine metabolism in health and disease.Randomized controlled studies on the efficacy of antiarthritic agents in inhibiting cartilage degeneration and pain associated with progression of osteoarthritis in the rat.Suppression of Th1 differentiation by tryptophan supplementation in vivo.The anti-allergic compound tranilast attenuates inflammation and inhibits bone destruction in collagen-induced arthritis in mice.Human embryonic stem cell-derived mesenchymal stromal cells ameliorate collagen-induced arthritis by inducing host-derived indoleamine 2,3 dioxygenaseSuppression of experimental autoimmune glomerulonephritis by tryptophan.Suppression of the allogeneic response by the anti-allergy drug N-(3,4-dimethoxycinnamonyl) anthranilic acid results from T-cell cycle arrest.Biocompatibility and antifibrotic effect of UV-cross-linked hyaluronate as a release-system for tranilast after trabeculectomy in a rabbit model--a pilot study.Inhibition of interleukin-1β-induced matrix metalloproteinase expression in human corneal fibroblasts by tranilast.
P2860
Q28488150-DC4D4FC7-8923-46C0-B172-F60B73579512Q36207412-6695A470-0AE1-4809-B195-F3ADFE39C760Q37028313-5CF9916A-6927-4F5D-B969-25D1F45C4DBDQ37802769-54DB7DC2-2757-4F9C-A452-32BBB83984FBQ38800946-4E224E97-9A40-42D2-A60C-3E6C6F9C6D1AQ38831208-DB2D6DC5-8AF0-452A-8E76-4582F9D35EF9Q39253354-5454F193-323A-4C52-AA4E-6983A5C719FDQ39804300-36761E1A-45CE-431E-873F-E8C9699BDAAEQ44850724-881C1D6F-DB19-4ACF-A582-63B8A13B96C7Q46526307-4931C714-F881-4299-AA7D-C5859A293FB6Q47777946-E46F89CB-926F-4235-B810-D7E806DEDCC4Q54220241-C4AA1455-A75A-4782-97EE-A9D906BB6514
P2860
The anti-allergic drug, N-(3',4'-dimethoxycinnamonyl) anthranilic acid, exhibits potent anti-inflammatory and analgesic properties in arthritis
description
im Juli 2007 veröffentlichter wissenschaftlicher Artikel
@de
scientific article published on 21 July 2007
@en
wetenschappelijk artikel
@nl
наукова стаття, опублікована в червні 2007
@uk
name
The anti-allergic drug, N-(3', ...... lgesic properties in arthritis
@en
The anti-allergic drug, N-(3', ...... lgesic properties in arthritis
@nl
type
label
The anti-allergic drug, N-(3', ...... lgesic properties in arthritis
@en
The anti-allergic drug, N-(3', ...... lgesic properties in arthritis
@nl
prefLabel
The anti-allergic drug, N-(3', ...... lgesic properties in arthritis
@en
The anti-allergic drug, N-(3', ...... lgesic properties in arthritis
@nl
P2093
P356
P1433
P1476
The anti-allergic drug, N-(3', ...... lgesic properties in arthritis
@en
P2093
P304
P356
10.1093/RHEUMATOLOGY/KEM160
P577
2007-07-21T00:00:00Z